Previously, Collins et al. (1988) reported the susceptibility of splenectomized Saimiri sciureus boliviensis monkeys to infection with sporozoites of the Salvador I strain of Plasmodium vivax.
Subsequently, 2 separate anti-sporozoite vaccine trials were conducted using this model system. In the first (Collins et al., 1989) , 48 monkeys were challenged by intravenous inoculation of 10,000 sporozoites; 18 of 18 control animals developed patent parasitemia with prepatent periods of 14-39 days (median 18 days). In the second trial (Collins et al., 1990), 35 animals were inoculated with 10,000 sporozoites; 16 of 17 control animals developed patent parasitemia after prepatent periods of 16-37 days (median 19 days). In summary, each of 40 control monkeys was inoculated with 10,000 sporozoites; 39 developed patent parasitemia after prepatent periods of 14-39 days.
In attempts to determine the parameters of sporozoite-induced infection in Bolivian Saimiri monkeys further and to establish the potential usefulness of other species of South American monkeys for vaccine and immunologic studies, additional animals have been inoculated with sporozoites of the Salvador I strain of P. vivax whenever animals and infected mosquitoes were available. Attempts to induce infection in monkeys also were made using sporozoites that had been stored frozen for different periods. The results of these studies are reported here.
MATERIALS AND METHODS
The Salvador I strain of P. vivax was originally isolated from an infected human in the area ofCongrejera in the Department of La Paz, El Salvador (Collins et al., 1972) . This strain has been maintained by passage in Aotus and Saimiri monkeys and chimpanzees.
In addition to feral and laboratory-born S. boliviensis animals, feral Saimiri peruviensis (both green-headed and black-headed) and Saimiri guyanensis, Aotus nancymai, Aotus vociferans, Aotus azarae boliviensis, Aotus lemurinus griseimembra, and hybrid Aotus monkeys were available. Black-headed Saimiri imported from Peru are similar yet distinct from the S. boliviensis animals imported from Bolivia. We have elected to designate them as black-headed S. peruviensis because of their geographic origin, although they are probably more closely related to the black-headed animals from Bolivia. All monkeys were splenectomized either before or within 7 days after sporozoite inoculation. Many of the animals had been infected with different species of Plasmodium and cured before their current infection.
Monkeys were infected either by the intravenous inoculation of sporozoites from dissected salivary glands or the bites of infected mosquitoes. For sporozoite inoculation, the salivary glands were dissected into 20% fetal bovine serum/saline and crushed under a coverslip. The sporozoites were then washed from the slide, counted in a hemocytometer, and injected into the femoral vein of the monkeys. For bite transmissions, the mosquitoes were allowed to feed directly on the abdomen of tranquilized monkeys through the screen mesh of the cage. After engorgement, the salivary glands were dissected and graded 1 + (1-10 sporozoites), 2+ (11-100 sporozoites), 3+ (101-1,000 sporozoites), or 4+ (>1,000 sporozoites). The ratings were totaled for all the mosquitoes feeding on the monkey. Some monkeys were inoculated with sporozoites that had been stored frozen. Sporozoites were harvested from dissected salivary glands (as described above) into 50% fetal bovine serum/saline, distributed into vials, and then frozen and stored in the vapor phase of a liquid N2 freezer. No cryopreservative was used. Prior to inoculation, the sporozoites were thawed rapidly and injected into the femoral vein of the monkeys. Beginning 10-12 days after inoculation, thick and thin blood films were made daily according to the technique of Earle and Perez (1932) , stained with Giemsa, and the parasite counts recorded per #1 of blood. The Anophelesfreeborni mosquitoes were originally from Marysville, California, and have been maintained in the laboratory since 1944. The Anopheles dirus, originally from Thailand, were obtained from the Walter Reed Army Institute of Research, Washington, D.C. The Anopheles stephensi, from Delhi India, were obtained from the National Institutes of Health, Bethesda, Maryland. The Anopheles gambiae (G-3 strain), originally from The Gambia, were obtained from the London School of Hygiene and Tropical Medicine, London, U.K. All colonies had been maintained in our laboratory for many years.
RESULTS

Saimiri monkeys
Two S. boliviensis were fed upon by infected mosquitoes (Table I) . Both developed parasit-emia after 24 and 35 days. Twelve monkeys were inoculated with sporozoites from dissected salivary glands. Eleven of the 12 developed parasitemia after prepatent periods of 10-63 days. Four monkeys (SI-195, SI-220, SI-69, and SI-81), which were previously infected with the homologous strain of P. vivax and cured, had prepatent periods of 43, 53, and 63 days (monkey SI-220 failed to develop parasitemia). The median prepatent period for the remaining 8 monkeys was 24 days. Ten monkeys were inoculated with sporozoites that had been frozen for 11-402 days. Seven monkeys developed parasitemia with prepatent periods ranging from 16 to 53 days (median 32 days). Transmission was obtained with sporozoites developed in An. stephensi, An. dirus, and An. gambiae mosquitoes. Two S. guyanensis (from Guyana) were infected via the bites of infected An. stephensi mosquitoes. The prepatent periods were 17 and 31 days. Two types of Saimiri were obtained from Peru (Table II) . Two of the green-headed S. peruviensis were fed upon by infected mosquitoes. No infections were obtained. Seven of 10 monkeys inoculated intravenously with sporozoites developed parasitemia with prepatent periods ranging from 12 to 46 days. Four monkeys were inoculated with sporozoites that had been frozen for 312 days. Two monkeys developed parasitemia after 43 and 50 days.
One black-headed S. peruviensis was exposed to the bites of infected mosquitoes (Table II) ; no infection was obtained. Ten monkeys were inoculated intravenously with sporozoites; 9 monkeys developed parasitemia after prepatent periods of 12-35 days (median = 19 days). Five monkeys were inoculated with sporozoites that had been stored frozen for 312 days. Three of the 5 developed parasitemia after 39, 43, and 45 days.
Of 58 Saimiri inoculated, 45 developed parasitemia (4 following bites and 41 following intravenous inoculation). Infections were obtained with sporozoites that developed in each of the 4 species of mosquitoes. Mosquitoes had been infected by feeding on gametocytes in blood from 1 Aotus monkey, 1 Saimiri monkey, 8 chimpanzees, and a human with a laboratory-acquired infection. Twelve of 19 monkeys inoculated with sporozoites that had been stored frozen developed patent parasitemia.
Aotus monkeys
Six A. nancymai were fed upon by infected mosquitoes (Table III) . Only monkey AI-927 (previously infected with P. falciparum) devel-prepatent period of 24 days. Three monkeys were inoculated with sporozoites that had been frozen for 416 days. No infections were obtained. Two A. lemurinus griseimembra monkeys were challenged via mosquito bite and 3 by intravenous inoculation. One animal from each group (AI-43 and AI-51) developed patent parasitemia after 17 and 57 days, respectively. Four hybrid animals (3 A. azarae boliviensis x A. lemurinus griseimembra; 1 A. lemurinus griseimembra x [A. lemurinus griseimembra x A. azarae boliviensis]) were inoculated, 2 via mosquito bites and 2 via intravenous inoculation. One monkey (AO-489) developed detectable parasitemia after 20 days. One A. vociferans was fed upon by infected mosquitoes. No infection was obtained.
Of 41 Aotus monkeys inoculated, only 10 (2 via bites and 8 via intravenous inoculation) developed parasitemia. Sporozoites from An. stephensi, An. freeborni, An. dirus, and An. gambiae resulted in infection. Mosquitoes had been infected by feeding on gametocytes from 5 Aotus monkeys and 7 chimpanzees.
DISCUSSION
Although transmission was obtained by the bite of An. stephensi or An. gambiae mosquitoes to S. boliviensis, S. guyanensis, A. nancymai, and A. 1. griseimembra monkeys, the rate of transmission (4 of 7 to Saimiri and 2 of 14 to Aotus) was low. The successful induction of infection following intravenous inoculation of sporozoites (7 of 20 to Aotus and 27 of 32 to Saimiri) indicated that sporozoites produced in all 4 mosquito species were capable of inducing infection and that the rate of transmission was increased when larger numbers of sporozoites were introduced intravenously. It is apparent from these studies that the injection of large numbers of sporozoites is needed to increase the rate oftransmission of the Salvador I strain of P. vivax to monkeys. It suggests that sporozoites of the Salvador I strain are not highly infectious to monkeys. However, a similar result might occur if merozoites produced by the exoerythrocytic stage in monkeys were rarely infectious to monkey erythrocytes.
As in the previously reported studies, prepatent periods varied greatly. However, shorter prepatent periods appeared to be related to the injection of larger numbers of sporozoites.
Of particular interest was the induction of infection using sporozoites that had been stored frozen. Jeffery and Rendtorff(1955) reported on the successful infection of human patients with sporozoites of P. vivax that had been stored at -70 C in plasma or serum-saline for up to 375 days. Presented here is the first report of the successful transmission ofP. vivax to monkeys using sporozoites that had been frozen. One of 7 attempts to infect Aotus and 12 of 19 attempts to infect Saimiri were successful. Because the prepatent periods for those animals inoculated with sporozoites that had been stored frozen were much longer than obtained with unfrozen sporozoites, it is assumed that a high percentage of sporozoites failed to survive the freezing and thawing process. An improved method for storing viable sporozoites is needed.
In the quest for suitable models for immunologic and biologic studies with the human malarias, most of the infections in monkeys have been induced via the inoculation of parasitized erythrocytes. We report here that the Salvador I strain of P. vivax may be suitable for many studies requiring sporozoite-induced infections. These observations suggest that: (1) Saimiri are more susceptible than Aotus monkeys; (2) intravenous inoculation of sporozoites is more apt to result in infection than mosquito bite (this may be related to the number of sporozoites available); (3) sporozoites from any of the 4 species of mosquito examined are infectous; and (4) sporozoites that have been stored frozen were infectious to monkeys. Based on these observations, the vaccinetesting model of the Salvador I strain of P. vivax using S. boliviensis monkeys and intravenous challenge with large numbers of sporozoites is the most predictable. Whether or not additional strains of P. vivax are more infectious to other species of Aotus and Saimiri monkeys remains to be demonstrated. 
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